HilleVax Statistics
Total Valuation
| Market Cap | n/a |
| Enterprise Value | n/a |
Important Dates
The last earnings date was Thursday, November 6, 2025, before market open.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HilleVax has 49.50 million shares outstanding. The number of shares has increased by 8.00% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 49.50M |
| Shares Change (YoY) | +8.00% |
| Shares Change (QoQ) | +0.27% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 49.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 26.39, with a Debt / Equity ratio of 0.16.
| Current Ratio | 26.39 |
| Quick Ratio | 25.96 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -28.25 |
Financial Efficiency
Return on equity (ROE) is -40.31% and return on invested capital (ROIC) is -15.31%.
| Return on Equity (ROE) | -40.31% |
| Return on Assets (ROA) | -14.48% |
| Return on Invested Capital (ROIC) | -15.31% |
| Return on Capital Employed (ROCE) | -31.02% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$5.08M |
| Employee Count | 14 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +14.21% in the last 52 weeks. The beta is 0.77, so HilleVax's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | +14.21% |
| 50-Day Moving Average | 2.09 |
| 200-Day Moving Average | 1.92 |
| Relative Strength Index (RSI) | 51.29 |
| Average Volume (20 Days) | 930,187 |
Short Selling Information
The latest short interest is 354,533, so 0.72% of the outstanding shares have been sold short.
| Short Interest | 354,533 |
| Short Previous Month | 241,142 |
| Short % of Shares Out | 0.72% |
| Short % of Float | 0.72% |
| Short Ratio (days to cover) | 0.36 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -52.35M |
| Pretax Income | -156.27M |
| Net Income | -71.10M |
| EBITDA | -50.91M |
| EBIT | -52.35M |
| Earnings Per Share (EPS) | -$1.43 |
Balance Sheet
The company has $159.55 million in cash and $23.54 million in debt, giving a net cash position of $136.01 million or $2.75 per share.
| Cash & Cash Equivalents | 159.55M |
| Total Debt | 23.54M |
| Net Cash | 136.01M |
| Net Cash Per Share | $2.75 |
| Equity (Book Value) | 147.82M |
| Book Value Per Share | 2.99 |
| Working Capital | 156.09M |
Cash Flow
In the last 12 months, operating cash flow was -$59.52 million and capital expenditures -$322,000, giving a free cash flow of -$59.84 million.
| Operating Cash Flow | -59.52M |
| Capital Expenditures | -322,000 |
| Free Cash Flow | -59.84M |
| FCF Per Share | -$1.21 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HilleVax does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.00% |
| Shareholder Yield | -8.00% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for HilleVax is $2.00, which is -4.31% lower than the current price. The consensus rating is "Hold".
| Price Target | $2.00 |
| Price Target Difference | -4.31% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |